Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMT | AMGN | VRTX | GILD | BMY |
| Company | Sagimet Biosciences Inc Series A | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.87 | 262.21 | 407.20 | 93.17 | 57.66 |
| High | 5.13 | 264.73 | 411.29 | 94.55 | 58.07 |
| Low | 4.78 | 261.76 | 406.02 | 92.97 | 57.51 |
| Last | 5.08 | 263.18 | 410.65 | 94.41 | 58.00 |
| Change | +0.14 | -1.31 | +2.47 | +0.46 | +0.24 |
| % Change | +2.83% | -0.50% | +0.61% | +0.49% | +0.42% |
| Volume | 317,628 | 1,602,444 | 1,184,057 | 2,825,251 | 4,449,397 |
| 20-Day Average Volume | 747,446 | 4,230,297 | 1,825,493 | 7,094,263 | 11,242,255 |
| Previous Close | 4.94 | 264.49 | 408.18 | 93.95 | 57.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.12 | 271.17 | 449.18 | 92.46 | 57.83 |
| 20-Day Raw Stochastic | 34.75% | 32.56% | 33.26% | 95.64% | 58.63% |
| 20-Day Relative Strength | 50.53% | 32.72% | 35.06% | 59.21% | 54.81% |
| Weighted Alpha | -45.45 | -15.18 | -7.12 | +26.94 | +21.20 |
| Today's Opinion | 40% Buy | 88% Sell | 72% Sell | 100% Buy | 96% Buy |
| Previous Opinion | 32% Buy | 88% Sell | 72% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 56% Buy | 72% Sell | 8% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.24% since 12/18/24 | +1.70% since 12/18/24 | -8.23% since 12/18/24 | +4.10% since 12/18/24 | +2.04% since 12/18/24 |
| Low | 4.78 on 12/26/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 90.27 on 12/19/24 | 56.08 on 12/20/24 |
| High | 5.40 on 12/19/24 | 269.61 on 12/20/24 | 411.29 on 12/26/24 | 94.55 on 12/26/24 | 58.07 on 12/26/24 |
| 1-Month | |||||
| %Chg | -1.74% since 11/26/24 | -6.01% since 11/26/24 | -12.08% since 11/26/24 | +3.35% since 11/26/24 | -1.26% since 11/26/24 |
| Low | 4.36 on 12/13/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 6.44 on 12/17/24 | 283.64 on 11/29/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | +80.14% since 09/26/24 | -17.52% since 09/26/24 | -11.34% since 09/26/24 | +13.69% since 09/26/24 | +15.72% since 09/26/24 |
| Low | 2.66 on 09/30/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 82.82 on 10/01/24 | 50.71 on 09/27/24 |
| High | 6.44 on 12/17/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +28.93% since 06/26/24 | -15.87% since 06/26/24 | -13.36% since 06/26/24 | +36.21% since 06/26/24 | +36.47% since 06/26/24 |
| Low | 2.39 on 08/14/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 6.44 on 12/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 151,534 | 142,172,096 | 105,118,176 | 117,086,688 | 117,147,504 |
| Shares Outstanding, K | 30,675 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 2,000,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -27,880,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -14,620,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 2.30 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 11/14/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/18/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 21.08 | 49.21 |